Is BG Medicine, Inc. (BGMD) a Buy, Sell, or Hold?
OTC : BGMD
BG Medicine, Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 450
- Average Volume
- 681
- Market Capitalization
- $1.14K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.47
- Current Ratio
- $1.65
Company Overview
OTC
Stephen Hall
Medical - Instruments & Supplies
Healthcare
BGMD
5
US
USD
Liquidity Metrics
0.00
1.65
1.53
1.29
-0.47
Sales & Valuation
$1.57M
0.00
0.00
0.00
-0.38
Profitability
-$0.55
-$5.3M
-338.63%
-338.63%
747.43%
-248.62%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
2 Analysts
%
Financial Health Scores
-115.94
4/9
$771K
$2.13M
$4.11M
-$5.14M
Key Metrics (TTM)
-$1.52M
-0.97
0.30
1.65
747.43%
-485.83%
-551855.02%
-322515.39%
-256 days
Company Executives
| Name | Title |
|---|---|
| Stephen Hall | Chief Financial Officer, Executive Vice President & Treasurer |
Poll Results
No votes yet today — be the first to share your view!
About BG Medicine, Inc. (OTC:BGMD) Stock
BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio includes the BGM Galectin-3 Test, an in vitro diagnostic solution that quantifies galectin-3 levels in blood serum or plasma using an enzyme-linked immunosorbent assay (ELISA) on a microtiter plate platform. Additionally, the company provides the CardioSCORE Test, a multi-analyte, biomarker-based blood test designed to assess the short-term risk of atherothrombotic cardiovascular events, such as myocardial infarction (heart attack) and ischemic stroke. BG Medicine maintains licensing, development, and commercialization agreements with major partners like Ab ... bott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc., specifically for automated versions of its galectin-3 test. Furthermore, it has forged a strategic alliance with Abbott Laboratories to jointly develop and market galectin-3 assay kits, along with their corresponding control kits and calibrators. Founded in 2000, the company was initially known as Beyond Genomics, Inc., before rebranding to BG Medicine, Inc. in October 2004. Its corporate headquarters are located in Waltham, Massachusetts.
Frequently Asked Questions
-
What is the current BG Medicine, Inc. (BGMD) stock price?
-
BG Medicine, Inc.(OTC:BGMD) stock price is $0.0001 in the last trading session. During the trading session, BGMD stock reached the peak price of $0.0001 while $0.0001 was the lowest point it dropped to. The percentage change in BGMD stock occurred in the recent session was 0.0% while the dollar amount for the price change in BGMD stock was $0.
-
BGMD's industry and sector of operation?
-
The OTC listed BGMD is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of BGMD?
-
Stephen Hall | Chief Financial Officer, Executive Vice President & Treasurer
|
|
|
| -
How many employees does BGMD have?
-
Number of BGMD employees currently stands at 5. BGMD operates from 303 Wyman Street, Waltham, MA 02451, US.
-
Link for BGMD official website?
-
Official Website of BGMD is: https://www.bg-medicine.com
-
How do I contact BGMD?
-
BGMD could be contacted at phone #781 890 1199 and can also be accessed through its website. BGMD operates from 303 Wyman Street, Waltham, MA 02451, US.
-
How many shares of BGMD are traded daily?
-
The average number of BGMD shares traded daily for last 3 months was 681.
-
What is the market cap of BGMD currently?
-
The market value of BGMD currently stands at $1.14K with its latest stock price at $0.0001